Symrise AG (SY1):企業の財務・戦略的SWOT分析

◆英語タイトル:Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15711
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥56,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Symrise AG (SY1) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It also provides biofunctional and bioactive ingredients and substances to the health and personal care sector. The company produces its products mainly on the basis of natural raw materials like vanilla, citrus fruits, onions, fish, meat, blossoms and plant materials. It serves perfume, cosmetics, food, pharma and nutritional supplements industries, and manufacturers of household products. The company has operational presence in the Europe, Africa, the Middle East, Asia Pacific, North America and Latin America. Symrise is headquartered in Holzminden, Niedersachsen, Germany.

Symrise AG Key Recent Developments

Mar 13,2019 Symrise successfully continues profitable growth course in 2018
Dec 19,2018 Symrise Executive Board members Heinrich Schaper and Jean-Yves Parisot early confirmed in office
Oct 11,2018 Committed to the environment: Symrise achieves second place in the German CSR Awards 2018
Aug 14,2018 Strong organic growth of 9.0 % in the first half of 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Symrise AG – Key Facts
Symrise AG – Key Employees
Symrise AG – Key Employee Biographies
Symrise AG – Key Operational Employees
Symrise AG – Major Products and Services
Symrise AG – History
Symrise AG – Company Statement
Symrise AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Symrise AG – Business Description
Business Segment: Flavor
Overview
Performance
Key Stats
Business Segment: Nutrition
Overview
Performance
Key Stats
Business Segment: Scent and Care
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EAME
Target Markets
Performance
Geographical Segment: Latin America
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
R&D Overview
Symrise AG – Corporate Strategy
Symrise AG – SWOT Analysis
SWOT Analysis – Overview
Symrise AG – Strengths
Symrise AG – Weaknesses
Symrise AG – Opportunities
Symrise AG – Threats
Symrise AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Symrise AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 13, 2019: Symrise successfully continues profitable growth course in 2018
Dec 19, 2018: Symrise Executive Board members Heinrich Schaper and Jean-Yves Parisot early confirmed in office
Oct 11, 2018: Committed to the environment: Symrise achieves second place in the German CSR Awards 2018
Aug 14, 2018: Strong organic growth of 9.0 % in the first half of 2018
Jul 12, 2018: Symrise wins German Sustainability Award 2019
Jul 11, 2018: Symrise continues dynamic growth track
May 12, 2018: Symrise strengthens its commitment to biodiversity conservation and ethical sourcing
May 08, 2018: Symrise Achieves Strong Organic Growth Of 7.5 % In First Quarter
May 08, 2018: Symrise achieves strong organic growth of 7.5 % in the first quarter
Apr 09, 2018: Symrise Retains Its Leading Position In Ethibel Sustainability Index Europe
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Symrise AG, Key Facts
Symrise AG, Key Employees
Symrise AG, Key Employee Biographies
Symrise AG, Key Operational Employees
Symrise AG, Major Products and Services
Symrise AG, History
Symrise AG, Subsidiaries
Symrise AG, Key Competitors
Symrise AG, Ratios based on current share price
Symrise AG, Annual Ratios
Symrise AG, Annual Ratios (Cont...1)
Symrise AG, Annual Ratios (Cont...2)
Symrise AG, Interim Ratios
Symrise AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Symrise AG, Performance Chart (2014 - 2018)
Symrise AG, Ratio Charts

★海外企業調査レポート[Symrise AG (SY1):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medical Research Council-製薬・医療分野:企業M&A・提携分析
    Summary Medical Research Council (MRC) is a human health research council that offers medical research programs. The council offers research across medical sciences services, universities and hospitals, centers and institutes. It provides data management, research platform, tools and facilities to g …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Robert Walters Plc (RWA):企業の財務・戦略的SWOT分析
    Summary Robert Walters Plc (Robert Walters) is a recruitment and consultancy service provider. The company offers placements of professionals on permanent, contract and interim positions. It provides recruitment services for accountancy and finance, banking and financial services, executive search, …
  • Franklin Covey Co. (FC):企業の財務・戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • The Mauritius Commercial Bank Limited:企業の戦略・SWOT・財務分析
    The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • PeptiDream Inc (4587)-製薬・医療分野:企業M&A・提携分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform. Its technologies i …
  • NextEra Energy Inc (NEE):企業の財務・戦略的SWOT分析
    NextEra Energy Inc (NEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gritstone Oncology Inc (GRTS):製薬・医療:M&Aディール及び事業提携情報
    Summary Gritstone Oncology Inc (Gritstone) develops and commercialize tumor-specific cancer immunotherapies. The company’s pipeline product portfolio comprises GRANITE-001, for solid tumors, including metastatic non-small cell lung cancer and gastroesophageal, bladder and colorectal cancers; and SLA …
  • The Hut Group Ltd:企業のM&A・事業提携・投資動向
    The Hut Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hut Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Sinochem International Corp (600500):企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析
    Summary Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytica …
  • Medibank Private Limited (MPL):企業の財務・戦略的SWOT分析
    Medibank Private Limited (MPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Muhibbah Engineering (M) Bhd:企業の戦略・SWOT・財務情報
    Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report Summary Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Cerevance Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinson's disease, L-Dopa induced dyskinesia, cognitive impairment, neuroinflammat …
  • Senior Lifestyle Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Senior Lifestyle Corp (Senior Lifestyle) is a healthcare service provider that provides healthcare and resident services. The company owns and operates several senior living apartments and retirement communities. It provides life enrichment programs such as cultural and social activities, tr …
  • Lucigen Corp:医療機器:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • RSA Insurance Group plc:企業のM&A・事業提携・投資動向
    RSA Insurance Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RSA Insurance Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Icahn Enterprises LP:企業のM&A・事業提携・投資動向
    Icahn Enterprises LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icahn Enterprises LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆